Pioneering DNA Methylation Diagnostics with INA^® Technology

Founded in 2006 and headquartered in Odense, Denmark, PentaBase is a leading Danish biotechnology company delivering innovative molecular diagnostics and genetic testing solutions. Established by Ulf B. Christensen, the company’s mission is to advance accurate, reliable PCR-based diagnostics for research and healthcare worldwide.

From the beginning, PentaBase focused on creating advanced molecular tools that improve the accuracy and efficiency of genetic analysis. Over the years, the company has made significant contributions in cancer diagnostics and infectious disease testing, earning recognition for its scientific expertise and innovation.

PentaBase is best known for its proprietary PCR technologies, including real-time PCR, digital PCR, and next-generation sequencing. These solutions provide enhanced sensitivity and specificity, allowing researchers and healthcare providers to deliver precise genetic analysis and reliable diagnostic results.
In addition, the company offers a wide range of diagnostic kits, reagents, and molecular tools designed to streamline workflows, reduce errors, and improve laboratory efficiency. Its products are widely used in clinical laboratories, academic research, and biotech applications, supporting advances in genetic testing and personalized medicine.

Through continuous research and development, PentaBase expands its product portfolio and technological capabilities. The company collaborates with academic institutions, research organizations, and industry partners to stay at the forefront of biotechnology innovation. Rigorous quality standards ensure reliable and reproducible results for every laboratory and healthcare provider.
Today, PentaBase is recognized as a global leader in molecular diagnostics. By combining innovation, quality, and collaboration, the company continues to revolutionize genetic testing, improve patient outcomes, and advance the field of precision medicine.